Search results for: “Macular degeneration”
Michael Berry
Michael Berry II, PhD, Associate Professor, Molecular Biology and the Princeton Neuroscience Institute Co-Director, Program in Neuroscience, Princeton University (and CEO of Optimal Acuity Corp.) Dr. Berry’s lab seeks to expand our understanding of how neurons combine to carry out powerful computations and has discovered that the retina carries out a diverse set of surprisingly…
Grantee Profiles and Publications
Saghar Bagheri, MD, PhD, Research Fellow in Ophthalmology, Harvard Medical School Michael Berry II, PhD, Associate Professor, Molecular Biology and the Princeton Neuroscience Institute Co-Director, Program in Neuroscience, Princeton University (and CEO of Optimal Acuity Corp.) Shun-Yun Cheng, PhD student Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School Kip Connor, PhD, (previously at)…
Resources
This section will be ever-expanding and evolving as we create or learn of valuable resources for the AMD community. Macular Degeneration Video LibraryAn ever-growing library of videos we have created on the topic of macular degeneration, covering everything from videos illustrating and explaining the disease, to cooking show segments, to the AMD Mind Body Spirit…
Study Demonstrates Essential Role of Zeaxanthin in Retina Health
Schepens/Harvard study provides direct proof of dietary nutrient’s essential role in protecting the retina from the damaging effects of light Research performed at Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School has established that the dietary zeaxanthin (zee-uh-zan’-thin) plays an essential role in protecting the retina of the eye from the damaging…
Study Indicates AMD Patients are at Higher Risk of COVID-19 Complications
A study conducted at New York Presbyterian/Columbia University Irving Medical Center, and published in Nature Medicine, indicates that patients with macular degeneration are at higher risk of complications due to COVID-19. The study, entitled “Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection,” looked at 6,398 COVID patients during the first wave of…
AMDF 2020 Year-In-Review and What’s Coming Up in 2021
2020. What a challenging year! Here at AMDF, our tight-knit team switched from regular, in-person meetings to a year of working remotely and, yes, using Zoom! Perhaps you have also discovered this, but, somehow, that break from our usual routines inspired us to think outside the box. Here are the highlights of 2020: COVID-19 Response…
Weight Reduction Can Decrease Risk of Late AMD
If you’re looking to improve your eye health, losing weight might be a good place to start. While it’s not a guaranteed cure for age-related macular degeneration (AMD), studies suggest that excess weight, especially around the waist, can increase your risk of developing advanced forms of AMD. What the Research Says A 2003 study by…
Raise Awareness
We look forward to the day that awareness of macular degeneration is as common as other major conditions, such as diabetes, or heart disease. Other than the juvenile form of macular degeneration (Stargardt’s), macular degeneration has several known modifiable risk factors. If you knew you could save your sight for longer, wouldn’t you want the…
AMDF Advocacy
The American Macular Degeneration Foundation is working toward securing access to the treatments, tools, and services that preserve vision and independence for all Americans with macular degeneration. Through our advocacy, we fight for you, and with you. We fight for your right to affordable treatments, tools, services, and technology, and your right to transportation access.…
What We Do
We are a small, but highly impactful organization, driven by passion to empower patients with macular degeneration by: Funding Critical Macular Degeneration Research More than anything else, people diagnosed with macular degeneration long for a cure. While cures for diseases as complex as macular degeneration can be elusive, research over the last few decades has…